PubAg

Main content area

Advances in liquid formulations of parenteral therapeutic proteins

Author:
Falconer, Robert J.
Source:
Biotechnology advances 2019
ISSN:
0734-9750
Subject:
acetates, biopharmaceuticals, histidine, liquids, monoclonal antibodies, pH, pain, patient compliance, polysorbates, statistical analysis, sucrose, surfactants, syringes, therapeutics, trehalose, viscosity
Abstract:
Liquid formulation of therapeutic proteins is a maturing technology. Demand for products that are easy to use in the clinic or that are amenable to self-administration make a ready to use liquid formulation desirable. Most modern liquid formulations have a simple composition; comprising a buffer, a tonicity modifier, a surfactant, sometimes a stabiliser, the therapeutic protein and water. Recent formulations of monoclonal antibodies often use histidine or acetate as the buffer, sucrose or trehalose as the tonicity modifier and polysorbate 20 or 80 as the surfactant with a pH of 5.7 +/− 0.4. The mechanisms for the behaviour of excipients is still debated by academics so formulation design is still a black art. Fortunately, a statistical approach like design of experiment is suitable for formulation development and has been successful when combined with accelerated stability experimentation. The development of prefilled syringes and pens has added low viscosity and shear resistance to the quality attributes for a successful formulation. To achieve patient compliance for self-administration, formulations that cause minimal pain and tissue damage is also desirable.
Agid:
6495411